RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:To the shorts of THCXI mean, fair enough. But what I'm trying to understand, and have yet to, is why you think THCX specifically is the best and right short opporutnity in the MJ space.
From what I've gathered you think it's because of their outsized share bonuses. While you might think $2.2m is outsized I've just shown you it's comprable to peers. You might say that some of those were issued at notably lower prices. Ok, but again most MJ stocks are higher compared to 6 months ago. So I don't really understand why you keep throwing around management bonuses as the reason to short THCX specifically.
Another commonality I've noticed from you is that you're doubting positive EBITDA will materialize. Again, this is a risk for all of the public LPs except they dont all have have 32% of their capacity earmarked by a publically disclosed qualified buyer and are trading at only 10x that sole disclosed amount. If anything, considering all the open capacity and the ability to compete on selling price and value-add products, THCX should trade at a higher multiple. Compared to other names in the space, it seems to me that to be short THCX, you're at a dis-advantage from the get go and I think the YTD preformance numbers show that.
Rothchildish wrote: Yeah, problem is, those shares were granted at much lower prices. Even then, 2.3M$ for a company burning money, we can talk about it all day. I've followed companies that were losing money and promised growing EBITDA, while maintaining high salaires and options grants, sadly, EBITDA never rose. Investors took the hit while management partied with their money, ouch.